|
 |
Ditropan XLThis page contains recent news articles, when available, and an overview of Ditropan XL but does not offer medical advice. You should contact your physician with regard to any health issues or concerns.Overview: Ditropan XL (when available) Oxybutynin is an antispasmodic, anticholinergic agent indicated for the treatment of overactive bladder with symptoms of urge urinary incontinence, urgency, and frequency. Oxybutynin relaxes bladder smooth muscle. Oxybutynin exhibits only one-fifth of the anticholinergic activity of atropine on the rabbit detrusor muscle, but four to ten times the antispasmodic activity. Antimuscarinic activity resides predominantly in the R-isomer. For the treatment of overactive bladder Mechanism Of Action: Oxybutynin exerts a direct antispasmodic effect on smooth muscle and inhibits the muscarinic action of acetylcholine on smooth muscle. No blocking effects occur at skeletal neuromuscular junctions or autonomic ganglia (antinicotinic effects). News Articles on Oxybutynin Generic Name: Oxybutynin, Ditropan XL - Nov 11, 2009 Ditropan (generic name: Oxybutynin) is used to decrease the urgency and the frequency of urination. Ditropan is used to control urgent, frequent, ... Pattaya Daily News … Prevails in Alza's Lawsuit Related to Generic Version of Ditropan... - Sep 29, 2005 Alza Pharmaceuticals markets Ditropan XL for the treatment of urge urinary ... According to NDCHealth, sales of Ditropan XL tablets were $395 million, ... RedOrbit Mylan Labs quarterly profitmore than doubles - Feb 1, 2007 N said on Thursday that quarterly profit more than doubled, and reported better-than-expected sales, helped by its generic version of the Ditropan XL ... Reuters Paparo v. Ortho McNeil Pharmaceutical, No. 05-81044-CIV-RYSKAMP/ … - Jan 10, 2007 Plaintiff claims that ingestion of Ditropan XL caused her to lose her teeth and ... Plaintiff recalls that such warned that Ditropan XL "causes dry mouth. ... $2.95 - U.S. District Court, Southern District... - VersusLaw … FDA Approval for Generic Version of Ditropan XL; First Approval in... - Feb 2, 2005 Alza Pharmaceuticals markets Ditropan XL for the treatment of urge ... US sales of Ditropan XL were approximately $410 million in the 12 months ended ... Free with registration - Business Wire - AccessMyLibrary.com IMPAX'S GENERIC DITROPAN XL APPROVED BY FDA - Nov 14, 2006 Impax Laboratories announced that the FDA has granted final approval to its abbreviated new drug application (ANDA) for a generic version of Ditropan XL ... Pay-Per-View - FDAnews Drug Pipeline Alert - Factiva, from Dow Jones IMPAX's ANDA for generic of Ditropan XL gets tentative FDA nod - Feb 3, 2005 US FDA has granted tentative approval to IMPAX Laboratories' Abbreviated New Drug Application (ANDA) for a generic version of Ditropan XL (Oxybutynin ... pharmabiz.com … Court Opinions - IN RE DITROPAN XL ANTITRUST LITIGATION (NDCal. … - Oct 11, 2007 10-11-2007) IN RE: DITROPAN XL ANTITRUST LITIGATION This Order Relates to: ALL CASES. ... Lavitsky Decl., ¶ 3 ("Cardinal's purchases of Ditropan XL from ... Pay-Per-View - Loislaw Federal District Court Opinions - Loislaw … Court Opinions - IN RE DITROPAN XL ANTITRUST LITIGATION (JPML … - Apr 17, 2006 IN RE DITROPAN XL ANTITRUST LITIGATION (JPML 2006) 429 F. Supp.2d 1364 IN RE DITROPAN XL ANTITRUST LITIGATION. City of Fargo Health Trust Fund v. ... Pay-Per-View - Loislaw Federal District Court Opinions - Loislaw … Court Opinions - IN RE DITROPAN XL ANTITRUST LITIGATION (NDCal. … - May 11, 2007 2007) 529 F. Supp.2d 1098 IN RE: DITROPAN XL ANTITRUST LITIGATION This Order ... Admittedly, Direct Purchaser Plaintiff did not purchase Ditropan XL from ... Pay-Per-View - Loislaw Federal District Court Opinions - Loislaw Press Release: Mylan Receives Final FDA Approval for Oxybutynin … - Nov 10, 2006 Oxybutynin Chloride ER Tablets are the generic version of Alza Corporation's Ditropan XL(R) Extended-release Tablets. Ditropan XL(R) had U.S. sales of ... Pay-Per-View - PR Newswire - HighBeam Research … US District Court Decision on DITROPAN XL(R) (Oxybutynin Chloride) - Sep 28, 2005 ALZA Corporation to Appeal US District Court Decision on DITROPAN XL(R) (Oxybutynin Chloride) Patent. from PR Newswire. Highbeam Research – FREE Trial. Pay-Per-View - PR Newswire - HighBeam Research … Court Opinions - IN RE DITROPAN XL ANTITRUST LITIGATION (NDCal. … - Nov 5, 2007 11-5-2007) IN RE: DITROPAN XL ANTITRUST LITIGATION This Document Relates to All Actions. No. MDL 06-1761 JSW (EDL). United States District Court, ... Pay-Per-View - Loislaw Federal District Court Opinions - Loislaw Press Release: IMPAX Receives Final FDA Approval. - M2 Presswire | … - Nov 10, 2006 Alza Pharmaceuticals markets Ditropan XL for the treatment of urge urinary ... U.S. sales of Ditropan XL 15 mg were approximately $58 million in the 12 ... Pay-Per-View - M2 Presswire - HighBeam Research Press Release: National Association for Female Executives (NAFE) … - Jan 25, 2005 They then received either Ditropan XL once a day in the morning ... PR Newswire. Article: ALZA's Ditropan XL Approved for Treatment of ... ... Pay-Per-View - PR Newswire - HighBeam Research IMPAX Receives Final FDA Approval for Generic Ditropan(R) XL 5 mg … - May 9, 2007 Alza Pharmaceuticals markets Ditropan XL for the treatment of urge urinary ... The Company's version of generic Ditropan XL is one of 12 products covered ... Genetic Engineering News - Genetic Engineering News (press release) Mylan approved to sell overactive bladder drug - Nov 10, 2006 Ditropan XL had US sales of roughly $380 million during fiscal 2006. Cecil Township-based Mylan (NYSE:MYL) is the first generic drug company to file ... Bizjournals.com Press Release: Mylan Announces Supply Agreement with Ortho-McNeil … - Dec 20, 2005 Pharmaceutical, Inc. markets DITROPAN XL in the U.S. and ALZA ... PR Newswire. Article: Ditropan XL a Significant Advance in Treating Urge ... ... Pay-Per-View - PR Newswire - HighBeam Research Allergan expands bladder role with Esprit deal - Sep 19, 2007 N) Ditropan XL, and Enablex, sold by Novartis (NOVN.VX) and Procter & Gamble Co (PG.N). Allergan said it aims to launch Sanctura XR in the first quarter of ... Reuters Impax drug gets final FDA approval - Nov 10, 2006 Ditropan XL is sold by Mountain View-based Alza Corp. to treat urge urinary ... This formulation of Ditropan XL (Oxybutynin Chloride) comes out of a ... Bizjournals.com … Court Opinions - IN RE DITROPAN XL ANTITRUST LITIGATION (NDCal. … - Jul 26, 2007 7-26-2007) IN RE: DITROPAN XL ANTITRUST LITIGATION This Order Relates to: ALL CASES. CASE NO. M:06-CV-01761-JSW, MDL No. 1761. United States District Court, ... Pay-Per-View - Loislaw Federal District Court Opinions - Loislaw Press Release: Mylan Receives Final FDA Approval for Oxybutynin … - Nov 13, 2006 Oxybutynin Chloride ER Tablets are the generic version of Alza Corporation's Ditropan XL Extended-release Tablets. Ditropan XL had U.S. sales of ... Pay-Per-View - M2 Presswire - HighBeam Research National Association for Female Executives (NAFE) Launches Healthcare... - Jan 25, 2005 Many overactive bladder sufferers are being successfully treated with prescription medications, such as DITROPAN XL(R) (oxybutynin chloride). ... $4.95 - PR Newswire - ECNext Bladder spasm at 3 am, when should I give Ditropan - Dec 27, 2008 Per the drug manufacturer's guidelines, oxybutynin chloride (Ditropan, Ditropan XL) needs to be taken regularly -- 2 to 3 times a day when using Ditropan, ... HealthCentral.com Milwaukee Journal Sentinel : DRUG CAPSULE WHAT YOU SHOULD … - Feb 27, 2006 What it does: Ditropan XL is a once-daily controlled-release tablet ... Interactions: Ditropan XL will add to the effects of alcohol and medicines that slow ... $2.95 - Milwaukee Journal Sentinel - NewsBank Article: The right message, better results: understanding--and... - Apr 1, 2007 Ditropan XL minimizes first-pass metabolism by ... day system. The important lesson for Ditropan XL (oxybutynin chloride) was that drug ... ... Pay-Per-View - Medical Marketing & Media - HighBeam Research Straits Gold Pty Ltd withdraws offer for Goldminco Corp-Tenements(2) ... - Sep 2, 2008 Ortho Biotech Inc.: Doxil; Ortho-McNeil Pharmaceuticals Inc.: Ditropan XL, Levaquin, Regranex… Storms continue. (F-N) · Storms continue. ... Pay-Per-View - deals - Alacra Store IMPAX Prevails in Alza's Appeal Related to Generic Version of... - Sep 7, 2006 Alza Pharmaceuticals markets Ditropan XL for the treatment of urge ... US sales of Ditropan XL were approximately $350 million in the 12 months ended May 31 ... Free with registration - Business Wire - AccessMyLibrary.com Healthcare Companies Making News! - May 9, 2007 Alza Pharmaceuticals markets Ditropan XL for the treatment of urge urinary incontinence. US sales of both the branded and generic 5 mg and 10 mg dosage ... Free with registration - M2 Presswire - AccessMyLibrary.com Press Release: Pharma Industry Study Finds Cadient Developed Web … - Jun 6, 2006 Ditropan XL Web Site Has Highest Success Rate of All Conditions and Web Sites ... "Our strategy for the Ditropan XL site was centered on removing the stigma ... Pay-Per-View - PR Newswire - HighBeam Research Loislaw Federal District Court Opinions - ALZA CORPORATION v. … - Sep 27, 2005 Therefore, its infringement argument marshals evidence of (1) bioequivalence data from Mylan's accused product and Ditropan XL, and (2) in vitro testing of ... Pay-Per-View - Loislaw Federal District Court Opinions - Loislaw The right message, better results: understanding--and improving--the ... - Apr 1, 2007 Analysis showed that Ditropan XL would need to deliver 15 percent more ... Other messages were less impactful: the dosage message for Ditropan XL had little ... Free with registration - Medical Marketing & Media - AccessMyLibrary.com … ; US FDA grants tentative approval for generic version of Ditropan... - Mar 4, 2005 Alza Pharmaceuticals markets Ditropan XL for the treatment of urge ... US sales of Ditropan XL were approximately $410 million in the 12 months ended ... Pay-Per-View - Drug Week - Factiva, from Dow Jones … Upholds Decision The Company Didn't Infringe on DITROPAN XL Pa - Sep 7, 2006 Circuit upheld a district court decision that Mylan's Oxybutynin products do not infringe a patent for DITROPAN XL(R) and that the patent was invalid. ... StreetInsider.com - StreetInsider.com (subscription) Press Release: Tengion Launches Third Phase 2 Clinical Trial of … - Jan 3, 2008 Article: Ditropan XL a Significant Advance in Treating Urge ... PR Newswire; July 17, 2001 ; 700+ words ... ... diagnosed and under treated. ... Pay-Per-View - PR Newswire - HighBeam Research … ; US FDA grants tentative approval for generic version of Ditropan... - Feb 28, 2005 Alza Pharmaceuticals markets Ditropan XL for the treatment of urge ... US sales of Ditropan XL were approximately $410 million in the 12 months ended ... Pay-Per-View - Health & Medicine Week - Factiva, from Dow Jones Neuromed Licenses Phase 3 Chronic Pain Product from ALZA … - Apr 24, 2007 CONCERTA(R), DITROPAN XL(R), OROS(R), and PUSH-PULL(TM) are trademarks of ALZA Corporation; JURNISTA(TM) is a trademark of Janssen-Cilag; PROCARDIA XL(R) is ... Free with registration - PR Newswire - AccessMyLibrary.com Bladder Medication May Lead to Some Memory Loss - May 25, 2006 Kay found that those taking Ditropan XL scored significantly worse on the memory tests compared with those taking Enablex or placebo. ... Daily of the University of Washington - The Daily of the University of Washingto... Mylan, J&J reach agreements on Ditropan - Dec 21, 2005 Johnson & Johnson's patents on Ditropan XL expire in 2015, according to the FDA. Southpointe-based Mylan has applied to sell 5 milligram and 10 milligram ... $2.95 - Observer-Reporter - NewsBank Weight loss probably not due to drinking gallons of water - Apr 20, 2006 I recently began to take Ditropan XL at night, and it works well for me. ... Ditropan XL (oxybutynin) calms overactive bladder muscles. ... SouthCoastToday.com - SouthCoastToday.com Allergan predicts big growth for bladder drug - Feb 7, 2008 N) Ditropan XL, and Enablex, sold by Novartis (NOVN.VX) and Procter & Gamble Co. (PG.N). Allergan in January launched a new once-daily form of its bladder ... Reuters Mylan Announces Supply Agreement with Ortho-McNeil on Oxybutynin. - Dec 20, 2005 Ortho-McNeil has also agreed to supply Mylan with a generic version of DITROPAN XL(R) sooner than a final appellate court decision if another generic ... Free with registration - PR Newswire - AccessMyLibrary.com Stress Incontinence Medications - Stress Incontinence Health Informati... - Apr 24, 2008 Extended-release versions of oxybutynin (Ditropan XL) and tolterodine (Detrol LA) are available. They improve continence and have fewer adverse effects than ... New York Times Oxybutynin may get a label rewrite, FDA says. - May 1, 2007 Ditropan XL, the extended-release formulation, is approved for children aged 6 years and older with detrusor overactivity associated with a neurologic ... Free with registration - Pediatric News - AccessMyLibrary.com Urinary Incontinence Medications - Urinary Incontinence Health … - Aug 12, 2008 Extended-release versions of oxybutynin (Ditropan XL) and tolterodine (Detrol LA) are proving to be especially effective. They improve continence and have ... New York Times Court of Appeals rules in favor of Mylan in Oxybutynin patent case - Sep 11, 2006 Circuit upheld a district court decision that Mylan's Oxybutynin products do not infringe a patent for DITROPAN XL and that the patent was invalid. ... News-Medical.net Generic Drugs; US FDA grants tentative approval for Oxybutynin... - Feb 14, 2005 Mylan believes it is the first generic drug company to file ANDAs with the FDA for 5 mg and 10 mg Ditropan XL, and as such, the company may be eligible for ... Pay-Per-View - Pharma Business Week - Factiva, from Dow Jones New Data Show Overactive Bladder Therapy Enablex(R) Does Not Impair … - May 23, 2006 In contrast, treatment with Ditropan XL(R)(i) (oxybutynin extended-release ... Enablex and Ditropan XL are indicated for the treatment of overactive bladder ... Free with registration - PR Newswire - AccessMyLibrary.com Hot Stocks to Watch! November 13, 2006. - Nov 13, 2006 Alza Pharmaceuticals markets Ditropan XL for the treatment of urge urinary ... US sales of Ditropan XL 15 mg were approximately $58 million in the 12 months ... $4.95 - M2 Presswire - ECNext US Court of Appeals Rules in Favor of Mylan in Oxybutynin Patent … - Oct 9, 2006 Circuit upheld a district court decision that Mylan's Oxybutynin products do not infringe a patent for DITROPAN XL and that the patent was invalid. ... ag-IP-news Agency Product News from the 11/14/06 News Brief - Nov 14, 2006 The FDA has granted Mylan Laboratories approval for its generic version of Alza Corporation's Ditropan XL (oxybutynin chloride extended-release) tablets. ... Medical Marketing & Media - Medical Marketing and Media Overactive Bladder Drugs Only Modestly Effective (press release) - Oct 25, 2006 In studies, Ditropan XL, Detrol LA, Oxytrol, Sanctura, Vesicare, and Enablex have caused fewer side effects. The report chose four Best Buys for people ... Natural News.com Generic Drugs; US FDA grants tentative approval for Oxybutynin... - Feb 15, 2005 Mylan believes it is the first generic drug company to file ANDAs with the FDA for 5 mg and 10 mg Ditropan XL, and as such, the company may be eligible for ... Pay-Per-View - Life Science Weekly - Factiva, from Dow Jones Newer agents for the management of overactive bladder.(Clinical... - Dec 15, 2006 Ditropan XL (oxybutynin chloride) [Package insert]. Mountain View, Calif.: ALZA, 2003. 4. Oxytrol (oxybutynin transdermal system) [Package insert]. ... $4.95 - American Family Physician - ECNext Generic Drugs; US FDA grants tentative approval for Oxybutynin... - Feb 20, 2005 Mylan believes it is the first generic drug company to file ANDAs with the FDA for 5 mg and 10 mg Ditropan XL, and as such, the company may be eligible for ... Pay-Per-View - Medical Letter on the CDC & FDA - Factiva, from Dow Jones Mylan Poised to Gain From $150 Billion Drug Windfall - Feb 7, 2008 ...from its flagship plant in Morgantown, including copies of Pfizer Inc.'s blood-pressure pill Norvasc and Johnson & Johnson's bladder drug Ditropan XL. ... Bloomberg Mylan Labs in Deal to Buy German Generic Drug Unit - May 14, 2007 Mylan specializes in copies of brand-name medicines that are difficult to make, like Johnson & Johnson's Duragesic pain patch and Ditropan XL bladder ... New York Times Mylan Receives Final FDA Approval for Oxybutynin Chloride Extended- … - Nov 13, 2006 Oxybutynin Chloride ER Tablets are the generic version of Alza Corporation's Ditropan XL Extended-release Tablets. Ditropan XL had US sales of approximately ... $4.95 - M2 Presswire - ECNext Tentative FDA OK for IMPAX generic Ditropan.(Food and drug … - Feb 7, 2005 Alza Pharmaceuticals markets Ditropan XL for the treatment of urge urinary incontinence and US sales of the drug were approximately $410.0 million in the 12 ... $4.95 - Pharma Marketletter - ECNext Press Release: Mylan Receives Tentative Approval for Oxybutynin … - Jan 18, 2005 Mylan believes it is the first generic drug company to file ANDAs with the FDA for 5 mg and 10 mg Ditropan XL(R), and as such, the company may be eligible ... Pay-Per-View - PR Newswire - HighBeam Research Press Release: New Prescription Pain Treatment Completes European … - May 15, 2006 ...announced today the intention ... Inc. markets DITROPAN XL in the U.S. and ALZA Corporation is the patent owner. DITROPAN XL is the first ... ... Pay-Per-View - PR Newswire - HighBeam Research First-time generic approvals.(FDA Drug Approvals) - Dec 1, 2006 Oxybutynin extendedrelease tablets, 15 mg (equiv to Ditropan XL extended-release tablets, 15 mg) Oxybutynin extended-release tablets, 5 and 10 mg (equiv to ... $4.95 - Formulary - ECNext SENS. KOHL, LEAHY INTRODUCE BILL TO STOP FRIVOLOUS CITIZEN … - Sep 28, 2006 Mylan laboratories, the maker of Ozybutynin, estimates that Ditropan XL generates more than $1.8 million in sales, daily. ... Pay-Per-View - US Fed News - Factiva, from Dow Jones Press Release: Mylan Wins Oxybutynin ER Patent Litigation. - PR … - Sep 28, 2005 Ditropan XL had U.S. sales of approximately $440 million during the 12-month period ended June 30, 2005, with more than 80% of the volume in the 5 mg and 10 ... Pay-Per-View - PR Newswire - HighBeam Research Press Release: ALZA Corporation Resubmits US New Drug Application … - Nov 28, 2005 ...announced today the intention ... Inc. markets DITROPAN XL in the U.S. and ALZA Corporation is the patent owner. DITROPAN XL is the first ... ... Pay-Per-View - PR Newswire - HighBeam Research Press Release: ALZA Corporation Modifies US Clinical Development … - Dec 1, 2005 ...announced today the intention ... Inc. markets DITROPAN XL in the U.S. and ALZA Corporation is the patent owner. DITROPAN XL is the first ... ... Pay-Per-View - PR Newswire - HighBeam Research Press Release: PPD Reports That ALZA Issued News Release on … - Oct 26, 2005 DITROPAN XL ... bladder. The suit was initiated by ALZA Corporation on May 2, 2003 in response to Mylan ... PR Newswire. Article: Johnson & Johnson and ALZA ... Pay-Per-View - PR Newswire - HighBeam Research Tenetative US appro for Mylan's oxybutynin.(Brief Article) - Jan 24, 2005 Mylan believes it is the first generic drug company to file ANDAs with the FDA for 5mg and 10mg Ditropan XL and, as such, the company may be eligible for ... $4.95 - Pharma Marketletter - ECNext Press Release: ALZA Corporation Receives Letter From FDA on … - Oct 26, 2005 DITROPAN XL ... bladder. The suit was initiated by ALZA Corporation on May 2, 2003 in response to Mylan ... PR Newswire. Article: Johnson & Johnson and ALZA ... Pay-Per-View - PR Newswire - HighBeam Research Press Release: New Data Show Overactive Bladder Therapy Enablex(R) … - May 23, 2006 In contrast, treatment with Ditropan XL(R)(i) (oxybutynin extended-release ... Enablex and Ditropan XL are indicated for the treatment of overactive bladder ... Pay-Per-View - PR Newswire - HighBeam Research Perils of corporate growth through takeovers - Nov 3, 2005 Two of Alza's big products, the attention-deficit treatment Concerta and the urinary incontinence treatment Ditropan XL, face generic threats. ... New York Times Article: FDA: Bladder drug needs stronger warning - The Record... - Apr 10, 2007 Article: ALZA's Ditropan XL Approved for Treatment of Overactive ... PR Newswire; December 17, 1998 ; 700+ words ... ... Drug Administration (FDA) to market ... Pay-Per-View - The Record - HighBeam Research Urinary Incontinence: Choices in Medical Therapy for Overactive... - Apr 1, 2007 Oxybutynin, extended-release (Ditropan XL) Oxybutynin, immediate-release (Ditropan) Oxybutynin, transdermal (Oxytrol) Propantheline (Pro-Banthine) ... $4.95 - Consultant - ECNext Highlights of rising and falling US stocks - MarketWatch - Sep 28, 2005 ...patent held by Johnson & Johnson's Alza Corp. for Ditropan XL extended-release tablets, a once-daily drug treatment for women with overactive bladders. ... MarketWatch FDA approves generic Impax drug - Dec 18, 2006 In November, the FDA approved the Hayward company's generic formulation of Urecholine, a urinary drug and its generic version of the drug Ditropan XL in ... Bizjournals.com Mylan Has Fourth-Quarter Loss on Research Writedown - May 24, 2007 ...copies of Johnson & Johnson's Duragesic pain patch, and it had exclusive rights to sell copies of J&J's Ditropan XL bladder medicine until May 9. ... Bloomberg AAN: Common Anticholinergics Speed Cognitive Decline - Apr 18, 2008 The most common were the urinary incontinence drugs tolterodine (28.57%) and oxybutynin (21.01% Ditropan and 21.01% Ditropan XL). ... MedPage Today Mylan's Pipeline Not Compelling Enough - Feb 3, 2006 He also likes Ditropan XL, which Mylan will likely launch after an appellate court decision given the recent deal with Johnson & Johnson (nyse: JNJ - news ... Forbes MARKET PLACE; Buyer's Remorse Is Causing Some Palpitations at … - Nov 3, 2005 Just four years after the purchase, two of Alza's big products, the attention-deficit treatment Concerta and the urinary incontinence drug Ditropan XL, ... New York Times J&J bladder drug reduces hot flashes: study - May 9, 2007 Researchers at George Washington University in Washington DC found that patients treated for 12 weeks with a 15 mg dose of Ditropan XL reported 2.4 daily ... Reuters High Expectations Sink Drug Stocks - Feb 6, 2006 ...generic drug opportunities and highlighted generic versions of Pfizer's Norvasc and Johnson & Johnson's (nyse: JNJ - news - people ) Ditropan XL. ... Forbes Next Five Years May Be 'Challenging' For J&J - Jan 30, 2006 These will be followed by generic threats to Concerta for attention deficit and hyperactivity disorder, Ditropan XL for overactive bladder, and, in Europe, ... Forbes The Allure Of Impax - Mar 14, 2005 In February, its Ditropan XL for urinary incontinence got a tentative OK It has 16 applications pending, with five tentatively approved. ... BusinessWeek Citi Sets Barr Higher, Mylan Lower - Oct 31, 2006 ...comes before the expected approval of its generic version of the overactive-bladder treatment Ditropan XL and the potential submission of an application ... TheStreet.com - TheStreet.com (subscription) Big opportunity seen for better bladder drugs - Jun 6, 2007 N) Ditropan XL. But sales of the so-called anti-cholinergic medicines, which work by blocking nerve messages to the bladder muscle, have been hobbled by ... Reuters Atlanta health, diet and fitness news | ajc.com - Sep 5, 2006 People taking any of the five drugs -- oxybutynin (Ditropan, Ditropan XL and Oxytrol, a skin patch); tolterodine (Detrol, Detrol LA); trospium (Sanctura); ... Atlanta Journal Constitution (JNJ) SqueezeTrigger Price is $62.442. There is $1,387,657,735.00... - Mar 4, 2008 DOXIL (doxorubicin HCI liposome injection), a cancer treatment; DITROPAN XL (oxybutynin chloride), for the treatment of overactive bladder; ... Free with registration - M2 Presswire - AccessMyLibrary.com Business news briefs: 11/11/06 - Nov 11, 2006 ...s Ditropan XL, which is used for the treatment of overactive bladder ... Waterford, Mich.-based Dunham's Sports will expand its Pittsburgh-area presence ... Pittsburgh Post-Gazette - Pittsburgh Post Gazette Ganancia de Mylan sube por genéricos - Feb 5, 2007 Mylan se ha beneficiado de ser el único fabricante en Estados Unidos de las versiones genéricas de Duragesic y Ditropan XL conforme los crecientes costos ... $2.95 - El Nuevo Herald - NewsBank Mylan Says Fiscal 2007 Earnings Exceeded Its Forecast - Apr 10, 2007 Mylan specializes in copies of brand-name medicines that are difficult to make, such as Johnson & Johnson's Duragesic pain patch and Ditropan XL bladder ... Bloomberg Pittsburgh Post-Gazette business briefs column. - Jan 19, 2005 Administration had granted tentative approval for its generic version of Ditropan XL, Ortho-McNeil Pharmaceutical's medication for overactive bladders. ... Free with registration - Pittsburgh Post-Gazette - AccessMyLibrary.com STARS USE CHARITIES TO MASK MISDEEDS - Feb 6, 2005 Finally, theres the spot for Ditropan XL, a medicine that counters OAB (overactive bladder, or urinary tract leakage). Side effects, the commercial tells us ... Pay-Per-View - New York Post - ProQuest Archiver Notebook: Medicare In Nursing Homes - May 9, 2006 Later the insurance company offers Ditropan XL, which is extended release oxybutinin, but Kerr wants no part of it. What did I take from watching Kerr fight ... CBS News Friday's biggest stock gainers and decliners. - Nov 10, 2006 Ditropan XL, a treatment for overactive bladders, had US sales of approximately $380 million in the 12 months ended June 30, 2006. ... Free with registration - America's Intelligence Wire - AccessMyLibrary.com Top 200 brand-name drugs by units in 2005.(rankings ) - Mar 20, 2006 Inderal LA 2898 -6.8 113 Vigamox 2823 29.5 114 Trileptal 2750 4.1 115 Low-Ogestrel 2729 -3.9 116 Ditropan XL 2645 -15.6 117 Dilantin Kapseals 2637 -17.2 ... Free with registration - Drug Topics - AccessMyLibrary.com Treating Bladder Control Problems - Aug 15, 2005 Medications: Overactive bladder drugs include Enablex (Novartis Pharmaceuticals), Ditropan XL (Ortho-McNeil), Oxytrol (Watson Pharmaceuticals), ... Pay-Per-View - Philadelphia Inquirer - Factiva, from Dow Jones Top 200 brand-name drugs by retail dollars in 2006.(COMMUNITY … - Feb 19, 2007 256183 15.8 124 Rhinocort Aqua 254697 -14.1 125 Norvir 249522 8.0 126 Tarceva 245470 64.2 127 Ditropan XL 244579 -17.4 128 Aldara 242947 7.1 129 NovoLog ... Free with registration - Drug Topics - AccessMyLibrary.com Urinary incontinence - Apr 28, 2006 Or you may want to try an extended-release form of oxybutynin (Ditropan XL) or tolterodine (Detrol LA) or an oxybutynin skin patch (Oxytrol). ... cnn.com Press Release: FDA Warns Consumers About Potential Problems at Two … - Aug 11, 2008 Ditropan XL, Extended-release Tablets, 15 mg (Oxybutynin Chloride Extended-release Tablets 15 mg). The FDA also awarded the Company first-to-file ... ... Pay-Per-View - M2 Presswire - HighBeam Research Article: NJ BRIEFS - The Record (Bergen County, NJ) | HighBeam … - Sep 7, 2006 ...after Mylan said it was seeking approval from the Food and Drug Administration to market a low-cost version of Alza's Ditropan XL incontinence drug. ... Pay-Per-View - The Record - HighBeam Research Article: P&G MAKES DEAL TO MARKET DRUG.(Business) - The … - Jul 7, 2005 ...treatment with Enablex(R) (darifenacin) did not result in ... American Urological Association (AUA). Enablex and Ditropan XL are indicated for the ... ... Pay-Per-View - Cincinnati Post - HighBeam Research Brand Names/Synonyms: Ditropan XL is also known by the following brand names and/or synonymsCCRIS 1923; CHEMBANK1678; Ditropan; Ditropan Xl; Ditropan Xl;; HSDB 3270; Oxibutinina [Inn-Spanish]; Oxibutyninum; Oxybutinin; Oxybutynin; Oxybutynin Base; Oxybutynin Chloride; Oxybutynin Hydrochloride; Oxybutynine [Inn-French]; Oxybutyninum [Inn-Latin]; Oxytrol Drug Category: Ditropan XL is categorized under the following by the FDA: Anticholinergic Agents; Antispasmodics; Genitourinary Smooth Muscle Relaxants; ATC:G04BD04 Dosage Forms: PATCH; SYRUP; TABLET; TABLET (EXTENDED-RELEASE) Absorption: Rapidly absorbed from gastrointestinal tract. Interactions: [an error occurred while processing this directive] Chemical IUPAC Name: 4-diethylaminobut-2-ynyl2-cyclohexyl-2-hydroxy-2-phenyl-ethanoate |
|
Health Home | Conditions | Cancer | Medications | Surgery | Vaccines The Cancer News Network
COPYRIGHT 2009 CANCERNEWSNETWORK | Privacy |